ELVN R&D Expenses
Enliven Therapeutics Inc · R&D Expenses
ELVN R&D Expenses
Latest reported$89.15Mperiod ending
ELVN TTM R&D Expenses ($19.01M → $89.15M)
TTM R&D Expenses
High-resolution chart · PNG
ELVN r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 89,153,000 | |
| 81,648,000 | |
| 85,856,000 | |
| 85,335,000 | |
| 88,368,000 | |
| 85,703,000 | |
| 80,778,000 | |
| 77,959,000 | |
| 76,307,000 | |
| 72,664,000 | |
| 64,574,000 | |
| 54,866,000 | |
| 43,089,000 | |
| 35,843,000 | |
| 31,022,000 | |
| 29,689,000 | |
| 32,257,000 | |
| 34,394,000 | |
| 34,450,000 | |
| 36,545,000 | |
| 35,681,000 | |
| 33,476,000 | |
| 32,154,000 | |
| 29,137,000 | |
| 24,745,000 | |
| 21,242,000 | |
| 19,009,000 |